Mindray shares a social responsibility to actively and continuously participate in the fight against coronavirus; more specifically, we see our role in this healthcare crisis tying directly back to our mission – to make the most advanced healthcare technology attainable to all.
MAHWAH, N.J. (PRWEB) April 06, 2020
As a leading developer and manufacturer of medical device solutions and technologies used in healthcare facilities around the globe, Mindray recognizes the extraordinary stress the coronavirus pandemic is creating within our nation’s healthcare system. With its North American headquarters in Mahwah, New Jersey, adjacent to the epicenter of the pandemic, the Mindray North America team is experiencing the ravaging effects of the virus firsthand, through the eyes of our customers, our trusted partners and our dedicated employees and their families.
“The increased pressure being put on our nation’s healthcare infrastructure is unprecedented, manifesting itself in many ways,” said Mindray North America President, Wayne Quinn. “As a manufacturer dedicated solely to the medical industry, Mindray shares a social responsibility to actively and continuously participate in the fight against coronavirus; more specifically, we see our role in this healthcare crisis tying directly back to our mission – to make the most advanced healthcare technology attainable to all, and we continue to shift our organizational focus toward doing just this.”
Given the extreme set of circumstances surrounding the coronavirus pandemic and the urgent need for ventilators, Mindray North America has put into action several key strategies to enable our customers to maximize the use of Mindray systems currently in place. The North American team has diligently worked with the US Food and Drug Administration (FDA) to gain clearance from the agency for conversion and off label use of Mindray A-Series anesthesia delivery systems as continuous ventilators. This immediately increases availability of critical mechanical ventilation across the country. In addition, we have also published procedures for switching the drive gas (utilized to fill the bellows required for mechanical ventilation) in the anesthesia/ventilator from oxygen to compressed air. The ability to implement this conversion helps healthcare providers to preserve oxygen, which is also in short supply, for use in directly treating patients.
Earlier this week, via an unprecedented global team effort, we not only successfully secured Emergency Use Authorization (EUA) from the FDA allowing import of our ventilators (which previously were not cleared for sale in the US), but also procured a defined supply of standalone ventilators, to be immediately shipped and distributed to key hospitals in New York City which are presently in dire need.
Finally, in anticipation of the increasing demand for vital signs, multi-parameter monitors (bedside and portable) and centralized monitoring systems, we have proactively ramped up production and supply of these products, while at the same time implementing procedures for simplified, rapid deployment of these systems. This pre-emptive move is enabling accelerated set up of ad hoc, ancillary treatment areas, while minimizing the need for onsite support and installation time.
The entire Mindray North America team remains fully committed to aiding our nation’s response to this pandemic illness. As an essential business, we continue to work, each and every day supporting healthcare providers across the nation as they serve on the front lines, defending the health of our nation, one patient at a time.
Mindray is a leading developer, manufacturer and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com.